Skip to content

Opioid Induced Hyperalgesia (OIH) Modulation With Propranolol

Opioid Induced Hyperalgesia (OIH) Modulation With Propranolol, in Laparoscopic Abdominal Surgery

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02934763
Enrollment
80
Registered
2016-10-17
Start date
2016-10-31
Completion date
2017-05-31
Last updated
2016-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperalgesia

Brief summary

Opioid Induced Hyperalgesia (OIH) is an entity than has been demonstrated in healthy volunteers and in animal models. Is defined as an increase in the perception to painful stimuli, increasing the opioid requirements and diminishing the pain thresholds to stimuli. The apparition of OIH is also related to the exposure to opioids during surgery, depending of the dose, the time of exposition and the type of opioid. This condition can be modulated, specially in the perioperative context. It has been seen in healthy volunteers and in animal models, than the use of propranolol can modulate this phenomena, diminishing the postoperative requirements of analgesia. It is also unknown, the dose of propranolol required to modulate adequately OIH. The objective of this work is to evaluate the efficacy of propranolol in the modulation of opioid induced hyperalgesia, with lower postoperative requirements of analgesia rescue.

Detailed description

This is a randomized controlled study, comparing 2 interventions with a placebo. The interventions will be use of propranolol, at different doses, to achieve specific plasmatic concentrations. 80 patients will be required to find a difference of 20% in the primary outcome. The primary outcome to be measured is the postoperative use of opioids in the post anesthesic care unit. Secondary outcomes, will be the amount of opioids used in the following 24 hours to the surgery, the time to the first dose of analgesia in the post anesthesic care unit, and the change in the pain thresholds, evaluated as pain by pressure and by tactile sensitivity, before and after surgery. Also, as a secondary outcome, in a group than will not receive the study drug, we will evaluate the temporal changes in opioid induced hyperalgesia, by pain sensitivity measured in the postoperative hours 2, 4 and 24. 10 patients receiving placebo will be part of this additional measures.

Interventions

DRUGPropranolol

propranolol iv by target controlled infusion, to achieve specific plasmatic concentration goals

DRUGSaline

Saline as placebo

Sponsors

Pontificia Universidad Catolica de Chile
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for elective laparoscopic cholecystectomy * American Society of Anesthesiology Score (ASA) I-II

Exclusion criteria

* Medical history of cardiac disease * Medical history of respiratory disease * Regular use of beta blockers * Known allergies to drugs used in the study * Known history of illicit drugs use

Design outcomes

Primary

MeasureTime frameDescription
Postoperative opioid use24 hours posterior to surgeryDose of opioid required to manage pain adequately

Secondary

MeasureTime frameDescription
Pain thresholds (heat)24 hours posterior to surgeryEvaluation of the threshold to perceive a heat perception as pain
Pain thresholds (cold)24 hours posterior to surgeryEvaluation of the threshold to perceive a cold perception as pain
Pain thresholds (tactile sensitivity)24 hours posterior to surgeryEvaluation of pain by tactile sensitivity, using the PinPrick system
Temporal changes in pain sensibility24 hours posterior to surgeryEvaluation of pain by tactile sensitivity, using the PinPrick system

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026